Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells

Among others, expression levels of programmed cell death 1 ligand 1 (PD‐L1) have been explored as biomarkers of the response to immune checkpoint inhibitors in cancer therapy. Here, we present the results of a chemical screen that interrogated how medically approved drugs influence PD‐L1 expression....

Descripción completa

Detalles Bibliográficos
Autores principales: Hühn, Daniela, Martí‐Rodrigo, Pablo, Mouron, Silvana, Hansel, Catherine, Tschapalda, Kirsten, Porebski, Bartlomiej, Häggblad, Maria, Lidemalm, Louise, Quintela‐Fandino, Miguel, Carreras‐Puigvert, Jordi, Fernandez‐Capetillo, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732350/
https://www.ncbi.nlm.nih.gov/pubmed/34392603
http://dx.doi.org/10.1002/1878-0261.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732350/
https://www.ncbi.nlm.nih.gov/pubmed/34392603
http://dx.doi.org/10.1002/1878-0261.13083

Ejemplares similares